Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Hepatology (Baltimore, Md.)|April 22, 2006
Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapyDonald M Jensen, Timothy R Morgan, Patrick Marcellin, et al.
Annals of Internal Medicine|March 5, 2004
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin doseStephanos J Hadziyannis, Hoel Sette, Timothy R Morgan, et al.
Journal of Hepatology|February 15, 2011
Management of hepatitis C virus genotype 4: recommendations of an international expert panelMahmoud A Khattab, Peter Ferenci, Stephanos J Hadziyannis, et al.
The New England Journal of Medicine|February 28, 2003
Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis BStephanos J Hadziyannis, Nicolaos C Tassopoulos, E Jenny Heathcote, et al.
The New England Journal of Medicine|July 1, 2005
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis BStephanos J Hadziyannis, Nicolaos C Tassopoulos, E Jenny Heathcote, et al.
Gastroenterology|November 8, 2006
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 yearsStephanos J Hadziyannis, Nicolaos C Tassopoulos, E Jenny Heathcote, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 25, 2012
Safety of peginterferon alfa-2a plus ribavirin in a large multinational cohort of chronic hepatitis C patientsSamuel S Lee, Stuart K Roberts, Hanna Berak, et al.
Gastroenterology|October 19, 2005
A dose-ranging study of the efficacy and tolerability of entecavir in Lamivudine-refractory chronic hepatitis B patientsTing-Tsung Chang, Robert G Gish, Stephanos J Hadziyannis, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 14, 2006
Chronic hepatitis B: a critical appraisal of current approaches to therapyRobert P Perrillo, Robert G Gish, Marion Peters, et al.
Pageof 5